Unlock unknown capital and drive efficiency while improving quality and scientist experience
Wednesday, June 17, 2009 at 10 AM EST
With increasing pressure in the pharmaceutical and biotech industry to reduce the costs of developing new drugs, more companies are looking at consolidating suppliers and partnering with global providers to enable them gain economies of scale, unify processes and increase productivity across all sites and functions.
More companies are starting to focus on their laboratory assets, how these are maintained, how validation is carried out, how downtime affects their operations and scientists’ productivity, how those assets are being utilized and whether they have over/under capacity.
Our lifecycle asset management programs go well beyond asset maintenance and provide you with a future proof solution that will improve scientist productivity, support capital investment strategies, help drive efficiency through multiple functions without compromising quality or scientist experience.
Register Free at www.pharmexec.com/datadriven